Prevention of congenital toxoplasmosis in France. Evaluation of risks. Results and prospects of prenatal screening and new-born follow-up;La prévention de la toxoplasmose congénitale en France. Évaluation des risques. Résultats et perspectives du dépistage anténatal et du suivi du nouveau-né

Bulletin de l'Academie Nationale de Medecine

Volumn 185, Issue 4, 2001, Pages 665-683

  Ambroise Thomas, Pierre ^a   Schweitzer, Michel ^b   Pinon, Jean Michel ^c   Thiebaugeorges, Olivier ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b Maternite Regionale Universitaire   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONGENITAL TOXOPLASMOSIS; FEMALE; FOLLOW UP; FRANCE; HUMAN; NEWBORN; NEWBORN SCREENING; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK ASSESSMENT;

FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT; TOXOPLASMOSIS, CONGENITAL;

EID: 0001312537     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)34515-7     Document Type: Article

References (78)

1. THULLIEZ P., ROMAND S. - Prenatal screening and prevention of congenital toxoplasmosis in France. In «Ambroise-Thomas P., Petersen E (Eds) : Congenital toxoplamosis. Scientific background, clinical management and control». Paris : Springer Verlag Ed., 2000, 293-298.
2. ASPOCK H., POLLAK A. - Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand. J. Infect. Dis, Suppl., 1992, 84, 32-37.
3. ASPOCK H. - Prevention of congenital toxoplasmosis in Austria : experience of 25 years. In «Ambroise-Thomas P., Petersen E (Eds) : Congenital toxoplamosis. Scientific background, clinical management and control». Paris : Springer Verlag Ed., 2000, 277-292.
4. AMBROISE-THOMAS P. - What informations should be extracted from the national programs for the prevention of congenital toxoplamosis in Austria and in France. In «Ambroise-Thomas P., Petersen E (Eds) : Congenital toxoplamosis. Scientific background, clinical management and control». Paris : Springer Verlag Ed., 2000, 299-303.
5. FOULON W., NAESSENS A., HO-YEN D. - Prevention of congenital toxoplamosis. J. Perinat. Med., 2000, 28, 337-345.
6. BUFFOLANO W., SAGLIOCCA L., FRATTA D., TOZZI A., CARDONE A., BINKIN N. - Prenatal toxoplasmosis screening in Campania region, Italy. Ital. Gynecol. Obstet., 1994, 6, 70-74.
7. LEBECH M., PETERSEN E. - Neonatal screening for congenital toxoplasmosis in Denmark : presentation of the design of a prospective study. Scand. J. Infect. Dis., Suppl., 1992, 84, 75-79.
8. WALLON M., LIOU C., GARNER P., PEYRON F. - Congenital toxoplasmosis : systematic review of evidence of efficacy of treatment in pregnancy. Br. Med. J., 1999, 318, 1511-1514.
9. ESKILD A., OXMAN A., MAGNUS P., BJORNDAL A., BAKKETEIG L.S. - Screening for toxoplasmosis in pregnancy : what is the evidence of reducing a health problem ? J. Med Screen., 1996, 3, 188-194.
10. FRENKEL J.K., DUBEY J.P. - Toxoplasmosis and its prevention in cats and man. J. Infect Dis., 1972, 126, 744-748.
11. BARIL L., ANCELLE T., GOULET V., THULLIEZ P., TIRARD-FLEURY V., CARME B. - Risk factors for Toxoplasma infection in pregnancy : a case-control study in France. Scand. J. Infect. Dis., 1999, 31, 305-309.
12. KAPPERED G., JENUM P.A., STRAY-PEDERSEN B., MELBY K., ESKILD A., ENG J. - Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am. J. Epidemiol., 1996, 144, 405-412.
13. COOK A.J., GILBERT R.E., BUFFOLANO W., ZUFFEREY J., PETERSEN E., JENUM P.A., FOULON W., SEMPRINI A.E., DUNN D.T - Sources of Toxoplasma infection in pregnant women : european multicentre case-control study. Br. Med. J., 2000, 321, 142-147.
14. BUFFOLANO W., GILBERT R.E., HOLLAND F.J., FRATTA D., PALUMBO F., ADES A.E. - Risk factors for recent Toxoplasma infection in pregnant women in Naples. Epidemiol. Infect., 1996, 116, 347-351.
15. DENKERS E.Y., GAZZINELLI R.T. - Regulation and function of Tcell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev., 1998, 11, 569-588.
16. SUBAUSTE S.C., SAWSON L., REMINGTON J.S. - Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii. J. Exp. Med., 1992, 176, 1511-1519.
17. ALEXANDER J., ROBERTS C.W., WALKER W., REICHMANN G., HUNTER C.A. - The immunology of Toxoplasma gondii infection in the immune-competent host. In «Ambroise-Thomas P., Petersen E (Eds) : Congenital toxoplamosis. Scientific background, clinical management and control». Paris : Springer Verlag Ed., 2000, 69-82.
18. ROTHOVA A. - Ocular involvement in toxoplasmosis. Br. J. Ophtalmol., 1992, 77, 371-377.
19. AMBROISE-THOMAS P., PELLOUX H. - Toxoplasmosis congenital and in immuno-compromised patients : a parallel. Parasitol. Today, 1993, 9, 61-62.
20. HOWE D.K., SUMMERS B.C., SIBLEY L.D. - Acute virulence in mice is associated with markers on chromosome VII in Toxoplasma gondii. Infect. Immun., 1996, 64, 5193-5198.
21. HOWE D.K., SIBLEY L.D. - Toxoplasma gondii comprises three clonal lineages : correlations of parasite genotype with human disease. J. Inf. Dis., 1995, 172, 1561-1566.
22. FRENKEL J.K., AMBROISE-THOMAS P. - Genetic drift of Toxoplasma gondii. Parasitol. Res., 1997, 83, 1-5.
23. TCHOBROUTSKY C., KEROS L., NATHAN G. Infections et grossesse : syphilis, toxoplasmose, rubéole, hépatite B, VIH, hépatite C, varicelle, cytomégalovirus, herpès simplex, Chlamydia trachomatis. In «Guide de surveillance de la grossesse ». Paris : ANDEM Ed, 1996, 129-144.
24. BRIARD M.L. - Données nationales sur le dépistage néonatal systématique et coordonné de la phénylcétonurie, de l'hypothyroïdie, et de l'hypoplasie congénitale des surrénales. Association pour le dépistage et la prévention des handicaps de l'enfant. La dépêche, 2000,38, 1-2.
25. DAFFOS F., FORESTIER F., CAPPELLA-PAVLOSKY M.D., THULLIEZ P., AUFRANT C., VALENTI D., COX W.L. - Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. New Engl. J. Med., 1988, 318, 271-275.
26. DESMONTS G., COUVREUR J. - Congenital toxoplasmosis. A prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy. Ann. Pédiatr., 1984, 31, 805-809.
27. PRATLONG F., BOULOT P., VILLENA I., ISSERT I., TAMBY I., CAZENAVE J., DEDET J.P. Antenatal diagnosis of congenital toxoplasmosis : evaluation of the biological parameters in a cohort of 286 patients. Br. J. Obst. Gyn, 1996, 103, 552-557.
28. DESMONTS G., REMINGTON J.S., COUVREUR J. - La Toxoplasmose congénitale. In «Vert P., Stren L. (Eds) Médecine Nénonatale». Paris : Masson Ed, 1985, 670-686.
29. KOPPE J.G., LOEWER-SIEGER D.H., DE ROEVER-BONNET H. - Results of 20 year follow-up of congenital toxoplasmosis. Lancet, 1986, 101, 254-255.
30. BEVERLEY J.K.A., ARCHER J.F., WATSON W.A., FAWCETT A.R. - Trial of a killed vaccine in the prevention of ovine abortion due to toxoplasmosis. Br. Vet. J., 1971, 127, 529-534.
31. FRENKEL J.K., PFEFFERKORN E.R., SMITH D.D., FISHBACK J.L. - A Toxoplasma vaccine for cats using a new mutant. Am. J. Vet. Res., 1991, 52, 759-763.
32. DUBEY J.P., BAKER D.G., DAVIS S.W., URBAN J.F., SKEN S.K. - Persistence of immunity to toxoplasmosis in pigs vaccinated with a non persistent strain of Toxoplasma gondii. Am. J. Vet. Res., 1994, 55, 982-987.
33. BUXTON D., INNES E.A. - A commercial vaccine for ovine toxoplasmosis. Parasitol., 1995, 110 (suppl.), 11-16.
34. NICOLAS J.A., PESTRE-ALEXANDRE M. - Toxoplasmose : une zoonose transmissible à l'homme. Méd. Mal. Infect., 1993, 23, 129-138.
35. AMBROISE-THOMAS P. - L'immunofluorescence dans le diagnostic direct et indirect des parasitoses : application à la toxoplasmose Lyon : Thèse Médecine, 1963, 160 p., 115 réf.
36. AMBROISE-THOMAS P., GARIN J.P., RIGAUD A. - Amélioration de la technique d'immunofluorescence par l'emploi de contre colorants. Application à la toxoplasmose. Presse Méd., 1966, 74, 2215-2216.
37. DE CHAMPS C., PELLOUX H., CAMNON M., FRICKER-HIDALGO H., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Evaluation of the second generation IMX Toxo IgG antibody assay for detection of antibodies to Toxoplasma gondii in human sera. J. Clin. Lab. Anal., 1997, 11, 214-219.
38. SABIN A., FELDMAN H.A. - Dyes as microchemical indicators of new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science, 1948, 108-660.
39. PETITHORY J.C., AMBROISE-THOMAS P., DE LOYE J., PELLOUX H., GOULLIER-FLEURET A., MILGRAM M., BUFFARD C., GARIN J.P. - Serodiagnosis of toxoplasmosis : a comparative study of a series of control sera using various currently available tests and expression of the results in international units. WHO Bull., 1996, 74, 291-298.
40. DESMONTS G., NAOT Y., REMINGTON J.S. - Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infection diseases : diagnosis of acute congenital and acquired Toxoplasma infection. J. Clin. Microbiol., 1981, 14, 486-491.
41. PELLOUX H., FRICKER-HIDALGO H., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Detection of anti- Toxoplasma Immunoglobulin M in pregnant women. J. Clin. Microbiol., 1997, 35, 2187.
42. FRICKER-HIDALGO H., PELLOUX H., RACINET C., BOST M., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Congenital toxoplasmosis : specific IgM in fetal blood, cord blood and in the new-born. Ann. Biol. Clin., 1996, 54, 165-168.
43. PINON J.M., THOANNES H., POULETTY P., POIRRIEZ J., DAMIENS J., PELLETIER P. - Detection of IgA specific for toxoplasmosis in serum and cerebrospinal fluid using non enzymatic IgA-capture assay. Diag. Immunol., 1986, 4, 223-227.
44. DECOSTER A., GONTIER P., DEHECQ E., DEMORY J.L., DUHAMEL M. - Detection of anti-Toxo IgA for diagnosis of acquired and congenital toxoplasmosis. J. Clin. Microbiol., 1995, 33, 2206-220.
45. PAUL M., GOULLIER-FLEURET A., PELLOUX H., AMBROISE-THOMAS P. - The importance of the detection of anti-IgA antibodies in acquired toxoplasmosis. Acta Parasitol., 1996, 4, 227-233.
46. PINON J.M., TOUBAS D., MARX C., MOUGEOT G., BONNIN A., BONHOMME A., VILLAUME M., FOUDRINIER F., LEPAN H. - Detection of specific immunoglobulin E in patients with toxoplasmosis. J. Clin. Microbiol., 1990, 28, 1739-1743.
47. PELLOUX H., BRUN E., VERNET G., MARCILLAT S., JOLIVET M., GUERGOUR D., FRICKER-HIDALGO H., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Determination of anti-Toxoplasma gondii immunoglobulin G avidity : adaptation to the Vidas system (bioMérieux). Diag. Microbiol. Infect. Dis., 1998, 32, 69-73.
48. PINON J.M., GRUSON N. - Intérêt des profils immunologiques comparés ELIFA dans le diagnostic précoce de la toxoplasmose congénitale. Lyon Méd., 1982, 248, 27-30.
49. PINON J.M., THOANNES H., GRUSON N. - An enzyme-linked immunofiltration assay used to compare infant and maternal antibody profiles in toxoplasmosis. J. Immunol. Meth., 1985, 77, 15-23.
50. PINON J.M., POIRRIEZ J., DUPOUY D., QUEREUX C., GARIN J., LEROUX B. - Diagnostic précoce et surveillance de la toxoplasmose congénitale : méthode des profils immunologiques comparés. Presse Méd., 1987, 16, 471-474.
51. PINON J.M., CHEMLA C., VILLENA I., FOUDRINIER F., AUBERT D., PUYGAUTHIER-TOUBAS D., LEROUX B., DUPOUY D., QUEREUX C., TALMUD M., TRENQUE T., POTRON G., PLUOT M., REMY G., BONHOMME A. - Early neonatal diagnosis of congenital toxoplasmosis : value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J. Clin. Microbiol., 1996, 34, 579-583.
52. CHUMPITAZI B.F.F., BOUSSAID A., PELLOUX H., RACINET C., BOST M., GOULLIER-FLEURET A. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J. Clin. Microbiol., 1995, 33, 1479-1485.
53. FRICKER-HIDALGO H., PELLOUX H., MUET F., RACINET C., BOST M., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Prenatal diagnosis of congenital toxoplasmosis : comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat. Diag., 1997, 17, 831-835.
54. FRICKER-HIDALGO H., PELLOUX H., RACINET C., GREFENSTETTE I., BOST-BRU C., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo and in vitro cultures. Placenta, 1998, 19, 545-549.
55. DEROUIN F., THULLIEZ P., CANDOLFI E., DAFFOS F., FORESTIER F. - Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur. J. Clin. Microbiol. Infect. Dis., 1998, 7, 423-425.
56. HOHLFELD P. DAFFOS F., COSTA J.M., THULLIEZ P., FORESTIER F., VIDAUD M. - Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N. Engl. J Med., 1994, 331, 695-699.
57. DUPOUY-CAMET J., BOUGNOUX M.E., LAVAREDA DE SOUZA S., THULLIEZ P., DOMMERGUES M., MANDELBROT L., ANCELLE T., TOURTE-SCHAEFER C., BENAROUS R. - Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis. Ann. Biol. Clin., 1992, 50, 315-319.
58. FOULON W., PINON J.M., STRAY-PETERSEN B., POLLAK A., LAPPALANEIM M., DECOSTER A., VILLENA I., JENUM P.A., HAYDE M., NAESSENS A. - Prenatal diagnosis of congenital toxoplasmosis : a multicenter evaluation of different diagnostic parameters. Am. J. Obstet. Gynecol., 1999, 181, 843-847.
59. PELLOUX H., WEISS J., SIMON J., MUET F., FRICKER-HIDALGO H., GOULLIER-FLEURET A., AMBROISE-THOMAS P. - A new set of primers for the detection of Toxoplasma gondii in amniotic fluid using polymerase chain reaction. FEMS Microbiol. Lett., 1996, 138, 11-15.
60. PELLOUX H., GUY E., ANGELICI M.C., ASPOCK H., BESSIERES M.H., BLATZ R., DEL PEZZO M., GIRAULT V., GRATZL R., HOLBERG-PETERSEN M., JOHNSON J., KRUGER D., LAPPALANEIM M., NAESSENS A., OLSSON M. - A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol. Lett., 1998, 165, 231-237.
61. DROULLE P., DIDIER F., SIMON E., BENOIT B., PAGLIAI F., GILLET J.Y. - Système nerveux central et rachis : aspects pathologiques. In «Gillet J.Y., Boog G., Dumez Y, Nisand I., Valette C. (Eds), Echographie des malformations fœtales». Paris : Vigot Ed., 1993, 59-75.
62. DUBEY J.P. - Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J. Parasitol., 1995, 81, 410-415.
63. FORESTIER F., DAFFOS F., RAINAUT M., DESNOTTES J.F., GASCHARD J.C. - Fetomaternal therapeutic follow-up of spiramycin during pregnancy. Arch. Fr. Pédiatr., 1987, 44, 539-544.
64. COUVREUR J., DESMONTS G., THULLIEZ P. - Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection. J. Antimicrob. Chemiother., 1988, 22, 193-200.
65. SCHOONDERMARK-VAN DE VEN E., GALAMA J., CAMPS W., VREE T., RUSSEL F., MEUWISSEN J., MELCHERS W. - Pharmakokinetics of spiramycin in the rhesus monkey : transplacental passage and distribution in tissues in the fetus. Antimicrob. Agents Chemothr., 1994, 38, 1922-1929.
66. FOULON W., VILLENA I., STRAY-PEDERSEN B., DECOSTER A., LAPPALAINEN M., PINON J.M., JENUM P.A., HEDMAN K., NAESSENS A. - Treatment of toxoplasmosis during pregnancy : a multicenter study of impact on fetal transmission and children's sequelae at one year of age. Am. J. Obstet. Gynecol., 1999, 180, 410-415.
67. BERREBI A., BESSIERES M.H., COHEN-CALAS Y., BLOOM M.C., ROLLAND M., SARRAMON M.F., ROQUES C., AMOUROUX J., FOURMIE A. - Diagnostic anténatal de la toxoplasmose. J. Gynécol. Obstétr. Biol. Reprod., 1993, 22, 261-268.
68. VILLENA I., AUBERT D., LEROUX B., DUPOUY D., TALMUD M., CHEMLA C., TRENQUE T., SCHMIT G., QUEREUX C., GUENOUNOU M., BONHOMME A., PINON J.M. - Pyrimethamine-sulfadoxine treatment of congenital Toxoplasmosis : follow-up of 78 cases between 1980 and 1997. Scand. J. Infect. Dis., 1998, 30, 295-300.
69. REMINGTON J.S., MC LEOD R., DESMONTS G. - Toxoplasmosis. In «Remington J.S., Klein J.O., (Eds). Infectious diseases of the fetus and newborn infant. 4th edition». Philadelphia : Saunders Ed. 1995, 140-267.
70. BARBOSA J., FERREIRA L. - Sulfadoxine-pyrimethamine (Fansidar) in pregnant women with Toxoplasma antibody titers. Curr. Chemother., 1978, 1, 134-135.
71. TRENQUE T., MARX C., QUEREUX C., LEROUX B., DUPOUY D., DORANGEON P., CHOISY H., PINON J.M. - Human maternofœtal distribution of pyrimethamine-sulphadoxine. Br. J. Clin. Pharmacol., 1998, 45, 179-180.
72. DORANGEON P.H., FAY R., MARX-CHEMLA C., LEROUX B., HARIKA G., DUPOUY D., QUEREUX C., CHOISY H., PINON J.M., WAHL P. - Passage transplacentaire de l'association pyriméthamine-sulfadoxine lors du traitement anténatal de la toxoplasmose congénitale. Presse Méd., 1990, 19, 2036.
73. MCLEOD R., MACK D., FOSS R., BOYER K., WITHERS S., LEVIN S., HUBBELL J. Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Antimicrob. Ag. Chemother., 1992, 36, 1040-1048.
74. BOULOT P., PRATLONG F., SARDA P., DESCHAMPS F., HEDON B., LAFFARGUE F., VIALA J.L. Limites du traitement prénatal de la toxoplasmose congénitale par l'association sulfadiazine-pyriméthamine. Presse Méd., 1990, 19, 570.
75. DAFFOS F., FORESTIER F. - Maladies infectieuses. I. La toxoplasmose. In «Médecine et Biologie du fœtus humain». Paris : Maloine Ed, 1998, 223-235.
76. COUVREUR J., THULLIEZ P., DAFFOS F., AUFRANT C., BOMPARD Y., GESQUIERE A., DESMONTS G. - In utero treatment of toxoplasmic fœtopathy with the combination pyriméthamine-sulfadoxine. Foetal Diagn. Ther., 1993, 8, 45-50.
77. THOULON J.M. - Toxoplasmose : prévenir, dépister, traiter. Gyn. Obst., 1999, 415, 4-5.
78. BADER T.J., MACONES G.A., ASCH D.A. - Prenatal screening for toxoplasmosis. Obst. Gynecol., 1997, 90, 457-464.